Abbott markets $14.5 billion for spinoff
By Michelle Sierra
NEW YORK | Wed Jun 20, 2012 9:03pm BST
(Reuters) - Details have emerged on the structure of the $14.5 billion financing package that backs Abbott Laboratories' (ABT.N) separation into two publicly traded companies, sources told Thomson Reuters LPC.
The facility includes a $7.5 billion bridge led by administrative agent Morgan Stanley, a $5 billion revolver led by administrative agent JP Morgan and a $2 billion revolver led by administrative agent BAML.